Intangible capital in the pharmaceutical chemical industry;.pdfVIP

Intangible capital in the pharmaceutical chemical industry;.pdf

  1. 1、本文档共22页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
University of New Orleans ScholarWorks@UNO Department of Economics and Finance Working Department of Economics and Finance Papers, 1991-2006 1-1-2003 Intangible capital in the pharmaceutical chemical industry; Katherine I. Gleason University of N ew Orleans Mark Klock George Washing ton University Follow this and additional works at : /econ_wp Recommended Citation Gleason, Katherine I. and Klock, Mark, Intangible capital in the pharmaceutical chemical industry; (2003). Department of Economics and Finance Working Pap ers, 1991-2006. Paper 10. /econ_wp/10 This Working Paper is brought to you for free and open access by the Department of Economics and Finance at ScholarWorks@UNO. It has been accepted for inclusion in Department of Economics and Finance Working Papers, 1991-2006 by an authorized administrator of ScholarWorks@UNO. For more information, please contact scholarworks@. February 2003 Intangible Capital in the Pharmaceutical Chemical Industry Katherine I. Gleason* ** Mark Klock contact: klock@ (202)994-8342 fax: (202)994-5014 *Assistant Professor of Finance, University of New Orleans, New Orleans, LA 70148 ** Professor of Finance, George Washington University, Washington, D.C. 20052 Abstract We investigate whether measures of intangible capital based on advertising and RD can explain variation in Tobin’s Q ratio for the pharmaceutical chemical industry using data from 1982 to 2001. The study is motivated by prior literature studying this relation in other

文档评论(0)

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档